North America Artificial Organ and Bionics Market 2022-2032 by Product Type , Material , Technology , Fixation Type , Age Group , End User , and Country: Trend Forecast and Growth OpportunityNorth America artificial organ and bionics market is projected to grow by 7.8% annually in the forecast period and reach $29.78 billion by 2032. The growth is driven by a rising incidence of organ failure due to lifestyle disorders and road accidents, scarcity of organ donors, increase in geriatric population, technological advancements in healthcare, the availability of cutting-edge artificial support systems, favorable reimbursement policies, and the increasing FDA approvals for implants. Highlighted with 29 tables and 60 figures, this 121-page report “North America Artificial Organ and Bionics Market 2022-2032 by Product Type (Organ, Bionics), Material (Metals, Polymers, Ceramics), Technology (Mechanical, Electronic), Fixation Type (Implantable, Wearable), Age Group (up to 17, 18-34, 35-49, 50-64, 65+), End User (Hospitals, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America artificial organ...Read more | USD 2,400.00 |
Europe Artificial Organ and Bionics Market 2022-2032 by Product Type , Material , Technology , Fixation Type , Age Group , End User , and Country: Trend Forecast and Growth OpportunityEurope artificial organ and bionics market was valued at $7.86 billion in 2022 and will grow by 8.0% annually over 2022-2032. The growth is driven by a rising incidence of organ failure due to lifestyle disorders and road accidents, scarcity of organ donors, increase in geriatric population, technological advancements in healthcare, the availability of cutting-edge artificial support systems, favorable reimbursement policies, and the increasing FDA approvals for implants. Highlighted with 36 tables and 64 figures, this 126-page report “Europe Artificial Organ and Bionics Market 2022-2032 by Product Type (Organ, Bionics), Material (Metals, Polymers, Ceramics), Technology (Mechanical, Electronic), Fixation Type (Implantable, Wearable), Age Group (up to 17, 18-34, 35-49, 50-64, 65+), End User (Hospitals, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe artificial organ and bionics market and all its sub-...Read more | USD 2,400.00 |
Asia Pacific Artificial Organ and Bionics Market 2022-2032 by Product Type , Material , Technology , Fixation Type , Age Group , End User , and Country: Trend Forecast and Growth OpportunityAsia Pacific artificial organ and bionics market will grow by 10.2% annually with a total addressable market cap of $133.85 billion over 2023-2032. The growth is driven by a rising incidence of organ failure due to lifestyle disorders and road accidents, scarcity of organ donors, increase in geriatric population, technological advancements in healthcare, the availability of cutting-edge artificial support systems, favorable reimbursement policies, and the increasing FDA approvals for implants. Highlighted with 33 tables and 65 figures, this 125-page report “Asia Pacific Artificial Organ and Bionics Market 2022-2032 by Product Type (Organ, Bionics), Material (Metals, Polymers, Ceramics), Technology (Mechanical, Electronic), Fixation Type (Implantable, Wearable), Age Group (up to 17, 18-34, 35-49, 50-64, 65+), End User (Hospitals, ASCs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific artificial organ...Read more | USD 2,400.00 |
Global Artificial Organ and Bionics Market 2022-2032 by Product Type , Material , Technology , Fixation Type , Age Group , End User , and Region: Trend Forecast and Growth OpportunityGlobal artificial organ and bionics market will reach $73.93 billion by 2032, growing by 8.5% annually over 2022-2032. The growth is driven by a rising incidence of organ failure due to lifestyle disorders and road accidents, scarcity of organ donors, increase in geriatric population, technological advancements in healthcare, the availability of cutting-edge artificial support systems, favorable reimbursement policies, and the increasing FDA approvals for implants. Highlighted with 88 tables and 96 figures, this 183-page report “Global Artificial Organ and Bionics Market 2022-2032 by Product Type (Organ, Bionics), Material (Metals, Polymers, Ceramics), Technology (Mechanical, Electronic), Fixation Type (Implantable, Wearable), Age Group (up to 17, 18-34, 35-49, 50-64, 65+), End User (Hospitals, ASCs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global artificial organ and bionics market and all its sub-segments...Read more | USD 3,000.00 |
Claudin 18.2 - Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from an Industry PerspectiveThis report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell therapy candidates from an industry perspective as of August 2023. CLDN18.2 is transmembrane protein selectively expressed on the cancer cell surface of gastric epithelial cells. The report brings you up-to-date with information about and analysis of Claudin 18.2 target identification and validation; Differential expression profile of claudin 18.2 in health and tumor tissues; Incidence of cancers with significant expression of claudin 18.2 in major countries; Scope and economic terms of licensing agreements for anti-CLDN18.2 immunotherapy candidates and discovery technologies; Stakeholders in the field: major pharma and biotech, ex-China biotech companies; Chinese major pharma and Chinese emerging biopharma companies; Specific company profiles, especially of Chinese,...Read more | USD 2,365.00 |